Ribon Therapeutics discovers and develops novel small molecule therapeutics for major unmet medical needs.
OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients.
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
Entrinsic Bioscience (formerly Entrinsic Health Solutions) is a company developing amino acid technology for the treatment of gastrointestinal disorders.
A2 Biotherapeutics is a biotechnology company that develops cell therapies for cancer patients.
Cambridge, US HQ
Charleroi, BE HQ
Marseille, FR HQ
Norwood, US HQ
Agoura Hills, US HQ
Twitter followers4.1 k
Latest funding round
Latest funding round$ 65m (over 1 year ago)
Latest funding round$ 20.6m (about 3 years ago)
Latest funding roundN/A
Latest funding round$ 49m (almost 2 years ago)
Latest funding round$ 71.5m (over 2 years ago)
Total funding raised
Total funding raised$ 65m
Total funding raised$ 29.8m
Total funding raised$ 94.1m
Total funding raised$ 58.2m
Total funding raised$ 128.5m